Codiak BioSciences, Inc. Operating Loss Carryforwards, Valuation Allowance
Codiak BioSciences, Inc. had Operating Loss Carryforwards, Valuation Allowance of $12.30 million as of 2021-12-31, per its 10-K filed 2022-03-10.
Discontinued › Notes › Income Taxes
us-gaap:OperatingLossCarryforwardsValuationAllowance · last filed 2022-03-10
- 2021-12-31: Operating Loss Carryforwards, Valuation Allowance $12.30M.
- 2020-12-31: Operating Loss Carryforwards, Valuation Allowance $27.50M.
- 2019-12-31: Operating Loss Carryforwards, Valuation Allowance $24.80M.
| Period end | Operating Loss Carryforwards, Valuation Allowance |
|---|---|
| 2021-12-31 | $12.30M 10-K · filed 2022-03-10 |
| 2020-12-31 | $27.50M 10-K · filed 2022-03-10 |
| 2019-12-31 | $24.80M 10-K · filed 2021-03-17 |